What are the immediate management and treatment options for acute vision loss due to differentials like central retinal artery occlusion, acute angle-closure glaucoma, retinal detachment, and optic neuritis?

Acute Vision Loss: Differential Diagnosis and Immediate Management

Central Retinal Artery Occlusion (CRAO)

CRAO is a medical emergency requiring immediate referral to an emergency department or stroke center without attempting further testing, as it represents an acute ischemic stroke with high risk of concurrent cerebrovascular events. 1

Immediate Actions

• Transfer immediately to a certified stroke center or emergency department - do not delay for additional ophthalmologic testing 1
• Direct communication with the stroke team is essential for appropriate triage 1
• Start antiplatelet therapy without delay 1

Acute Treatment Window (Within 4.5 Hours)

• Intravenous tissue plasminogen activator (tPA) may be considered for patients presenting within 4.5 hours of symptom onset 1, 2
• Hyperbaric oxygen therapy (100% oxygen over 9 hours) has shown efficacy in small randomized trials 2
• Treatment must be deployed within 6 hours of symptom onset to have any potential benefit 3

Critical Diagnostic Workup

• Brain MRI with diffusion-weighted imaging within 24 hours to identify concurrent silent brain infarctions, which occur in up to 25% of patients 2, 4
• Vascular imaging (MRA or CTA) of carotid arteries - clinically significant stenosis is found in up to 70% of patients 2, 4
• For patients over 50 years: urgent ESR and CRP to rule out giant cell arteritis (GCA), which requires immediate corticosteroid therapy 2, 4

Key Pitfall

The risk of stroke is highest within the first 7 days after retinal artery occlusion and remains elevated for 30 days - even if vision has reperfused, urgent stroke evaluation is still mandatory 2

---

Acute Angle-Closure Glaucoma

Acute angle-closure glaucoma requires immediate medical therapy to lower intraocular pressure, followed by definitive laser peripheral iridotomy within hours. 5

Immediate Medical Management (Sequential Approach)

• Topical timolol 0.5% (beta-blocker) to rapidly lower IOP 5
• Topical brimonidine 0.2% (alpha-2 agonist) for additional IOP reduction 5
• IV mannitol 1-2 g/kg or oral glycerol (hyperosmotic agents) for rapid IOP reduction 5, 6, 7
• Oral or IV acetazolamide (carbonic anhydrase inhibitor) - typical dosing is 250-500 mg IV initially 5, 6, 7
• Pilocarpine 1-2% only after IOP begins to decrease (ineffective when IOP is very high due to iris ischemia) 5, 8

Definitive Treatment

• Laser peripheral iridotomy (LPI) as soon as cornea clears enough to visualize the iris 5
• LPI should be performed in the superior iris to avoid visual symptoms 5
• Prophylactic LPI in the fellow eye is mandatory due to similar anatomic predisposition 5

Clinical Presentation

• Mid-dilated fixed pupil, corneal edema, conjunctival injection 5
• Ocular pain, headache, nausea 8

---

Retinal Detachment

Retinal detachment presents with a curtain-like visual field defect and usually requires urgent surgical intervention. 8

Clinical Features

• Painless vision loss with curtain or shadow across visual field 8
• May be preceded by flashes of light (photopsia) and floaters
• Requires immediate ophthalmologic referral for surgical repair 8

Management

• Urgent ophthalmology consultation for surgical intervention 8
• Surgical options include pneumatic retinopexy, scleral buckle, or vitrectomy depending on detachment characteristics

---

Optic Neuritis

Optic neuritis is a demyelinating condition requiring high-dose intravenous corticosteroids and evaluation for multiple sclerosis. 8

Clinical Features

• Pain with extraocular muscle movements (pathognomonic feature) 8
• Color desaturation (red desaturation is classic) 8
• Relative afferent pupillary defect (RAPD) 8
• Typically affects younger patients (20-40 years)

Treatment

• High-dose IV methylprednisolone (typically 1 gram daily for 3-5 days) 8
• Evaluation for multiple sclerosis with brain MRI 8
• Oral prednisone alone is contraindicated as it increases recurrence risk

---

Giant Cell Arteritis (GCA) - Critical Consideration Across All Differentials

For any patient over 50 years with acute vision loss, GCA must be ruled out immediately as it can cause irreversible bilateral blindness. 2, 4, 8

High-Risk Features

• Jaw claudication (most specific symptom, LR 4.90) 4
• Scalp tenderness, particularly over temporal arteries 8
• Constitutional symptoms: fever, weight loss, malaise 2
• Proximal muscle and joint pain (polymyalgia rheumatica) 8
• ESR >60 mm/h has high likelihood ratio for GCA 4

Immediate Management

• Start high-dose IV corticosteroids immediately (methylprednisolone 1 gram daily) before biopsy confirmation to prevent vision loss in the fellow eye 2, 8
• Urgent temporal artery biopsy (can be performed up to 2 weeks after starting steroids) 8
• Do not delay steroid treatment waiting for biopsy results 2

---

Universal Principles for Acute Vision Loss Management

Time-Critical Actions

• All acute vision loss should be treated as an emergency requiring same-day evaluation 1
• The window for effective intervention is typically 4.5-6 hours for vascular occlusions 1, 3
• Risk of stroke is maximum within first few days after onset of visual symptoms 4

System-Level Approach

• Develop local networks connecting optometrists, ophthalmologists, and stroke neurologists 1, 4
• Public education campaigns should include vision loss as stroke warning sign ("BE-FAST" instead of "FAST") 1
• Only one-third of ophthalmologists currently transfer retinal artery occlusion patients to emergency departments despite guidelines - this practice must change 2